The Journal of small animal practice · 2026
Combined phallopexy and preputial advancement for the treatment of paraphimosis of unknown aetiology in 16 dogs.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Badham H, Cathrall G, Cockburn E, Das S
Аннотация
OBJECTIVES: To report the medium- to long-term outcomes and complications of a larger case series of patients undergoing combined phallopexy and preputial advancement for treatment of paraphimosis of unknown aetiology.
MATERIALS AND METHODS: Retrospective case series: Medical records of a single small animal referral centre were searched for male dogs treated for idiopathic paraphimosis with combined phallopexy and preputial advancement between January 2010 and October 2023. Data collected included signalment, presenting clinical signs, surgical technique, peri-/post-operative complications and outcome. Outcome was based on owner questionnaire.
RESULTS: Sixteen dogs met the inclusion criteria and were included in the study. Median surgical time was 60 minutes (45 to 75 minutes) and there were no intraoperative complications. Two of the 16 (12.5%) dogs had major complications. One of the 16 (6.25%) cases had minor complications. Eight dogs (50%) had no recurrence of paraphimosis following surgery, three (18.75%) had some intermittent recurrence requiring no treatment, three (18.75%) had intermittent recurrence requiring occasional medical management but an improvement from presurgical condition and two dogs (12.5%) had no major improvement from pre-surgical condition.
CLINICAL SIGNIFICANCE: In conclusion, preputial advancement and phallopexy can be used to treat paraphimosis refractory to medical management with reasonable levels of success leading to improvement in 87.5% (14/16) of dogs. However, complication rates and risk of recurrence are similar to those previously reported with phallopexy or preputial advancement alone.
MATERIALS AND METHODS: Retrospective case series: Medical records of a single small animal referral centre were searched for male dogs treated for idiopathic paraphimosis with combined phallopexy and preputial advancement between January 2010 and October 2023. Data collected included signalment, presenting clinical signs, surgical technique, peri-/post-operative complications and outcome. Outcome was based on owner questionnaire.
RESULTS: Sixteen dogs met the inclusion criteria and were included in the study. Median surgical time was 60 minutes (45 to 75 minutes) and there were no intraoperative complications. Two of the 16 (12.5%) dogs had major complications. One of the 16 (6.25%) cases had minor complications. Eight dogs (50%) had no recurrence of paraphimosis following surgery, three (18.75%) had some intermittent recurrence requiring no treatment, three (18.75%) had intermittent recurrence requiring occasional medical management but an improvement from presurgical condition and two dogs (12.5%) had no major improvement from pre-surgical condition.
CLINICAL SIGNIFICANCE: In conclusion, preputial advancement and phallopexy can be used to treat paraphimosis refractory to medical management with reasonable levels of success leading to improvement in 87.5% (14/16) of dogs. However, complication rates and risk of recurrence are similar to those previously reported with phallopexy or preputial advancement alone.